HomeLEXX • NASDAQ
add
Lexaria Bioscience Corp
Previous close
$0.87
Day range
$0.82 - $0.97
Year range
$0.79 - $4.38
Market cap
18.49M USD
Avg Volume
132.16K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
(USD) | May 2025info | Y/Y change |
---|---|---|
Revenue | 174.00K | 107.14% |
Operating expense | 3.92M | 114.81% |
Net income | -3.79M | -112.67% |
Net profit margin | -2.18K | -2.67% |
Earnings per share | — | — |
EBITDA | -3.72M | -115.27% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | May 2025info | Y/Y change |
---|---|---|
Cash and short-term investments | 4.63M | -45.62% |
Total assets | 6.74M | -32.71% |
Total liabilities | 1.57M | 480.32% |
Total equity | 5.17M | — |
Shares outstanding | 19.56M | — |
Price to book | 3.11 | — |
Return on assets | -121.62% | — |
Return on capital | -154.11% | — |
Cash Flow
Net change in cash
(USD) | May 2025info | Y/Y change |
---|---|---|
Net income | -3.79M | -112.67% |
Cash from operations | -3.58M | -183.08% |
Cash from investing | -19.44K | 11.63% |
Cash from financing | 1.69M | -66.51% |
Net change in cash | -1.88M | -150.01% |
Free cash flow | -2.66M | -171.39% |
About
Founded
2004
Website
Employees
7